Medication Assisted Treatment Therapies

• Buprenorphine
  On October 8, 2002 the Schedule III narcotic medications Subutex® (buprenorphine hydrochloride) and Suboxone® tablets (buprenorphine hydrochloride and naloxone hydrochloride) received FDA approval for the treatment of opioid addiction.



• CSAT's Division of Pharmacologic Therapies
  CSAT's Division of Pharmacologic Therapies (DPT) manages the day-to-day regulatory oversight activities necessary to implement new SAMHSA regulations (42 CFR Part 8) on the use of Opioid agonist medications (methadone and LAAM) approved by the Food and Drug Administration (FDA) for addiction treatment.



• Physician(s) Authorized to Prescribe Buprenorphine
  The Physician Locator is an on-line resource designed to assist the States, medical and addiction treatment communities, potential patients, and/or their families in finding information on locating physicians who can prescribe buprenorphine (Suboxone® and Subutex®) for treatment of opioid addiction.



• Methadone
  Methadone is the most common medication for heroin addiction treatment and also the most controversial. This Web area provides information about the background, Methadone maintenance, references, and program directories for treatment.